LICHEN INTERNATIONAL LTD (LICN) Fundamental Analysis & Valuation

NASDAQ:LICNKYG5479G1165

Current stock price

3 USD
-0.01 (-0.33%)
Last:

This LICN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LICN Profitability Analysis

1.1 Basic Checks

  • In the past year LICN has reported negative net income.
  • In the past year LICN has reported a negative cash flow from operations.
  • LICN had positive earnings in 4 of the past 5 years.
  • Of the past 5 years LICN 4 years had a positive operating cash flow.
LICN Yearly Net Income VS EBIT VS OCF VS FCFLICN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • LICN's Return On Assets of -24.20% is on the low side compared to the rest of the industry. LICN is outperformed by 85.06% of its industry peers.
  • LICN has a Return On Equity of -25.31%. This is in the lower half of the industry: LICN underperforms 73.56% of its industry peers.
Industry RankSector Rank
ROA -24.2%
ROE -25.31%
ROIC N/A
ROA(3y)7.28%
ROA(5y)12.15%
ROE(3y)8.07%
ROE(5y)14.07%
ROIC(3y)N/A
ROIC(5y)N/A
LICN Yearly ROA, ROE, ROICLICN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • LICN has a Gross Margin of 56.60%. This is in the better half of the industry: LICN outperforms 74.71% of its industry peers.
  • LICN's Gross Margin has been stable in the last couple of years.
  • LICN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5YN/A
LICN Yearly Profit, Operating, Gross MarginsLICN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

9

2. LICN Health Analysis

2.1 Basic Checks

  • LICN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LICN has less shares outstanding
  • LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LICN Yearly Shares OutstandingLICN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
LICN Yearly Total Debt VS Total AssetsLICN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • LICN has an Altman-Z score of 11.11. This indicates that LICN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of LICN (11.11) is better than 95.40% of its industry peers.
  • LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.11
ROIC/WACCN/A
WACC7.54%
LICN Yearly LT Debt VS Equity VS FCFLICN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • LICN has a Current Ratio of 10.19. This indicates that LICN is financially healthy and has no problem in meeting its short term obligations.
  • LICN's Current ratio of 10.19 is amongst the best of the industry. LICN outperforms 97.70% of its industry peers.
  • A Quick Ratio of 10.19 indicates that LICN has no problem at all paying its short term obligations.
  • LICN's Quick ratio of 10.19 is amongst the best of the industry. LICN outperforms 97.70% of its industry peers.
Industry RankSector Rank
Current Ratio 10.19
Quick Ratio 10.19
LICN Yearly Current Assets VS Current LiabilitesLICN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

1

3. LICN Growth Analysis

3.1 Past

  • LICN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -215.99%.
  • The Revenue for LICN has decreased by -10.23% in the past year. This is quite bad
  • LICN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.54% yearly.
EPS 1Y (TTM)-215.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.19%
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y6.54%
Revenue growth 5YN/A
Sales Q2Q%-21.2%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LICN Yearly Revenue VS EstimatesLICN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

4. LICN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LICN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LICN Price Earnings VS Forward Price EarningsLICN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LICN Per share dataLICN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. LICN Dividend Analysis

5.1 Amount

  • No dividends for LICN!.
Industry RankSector Rank
Dividend Yield 0%

LICN Fundamentals: All Metrics, Ratios and Statistics

LICHEN INTERNATIONAL LTD

NASDAQ:LICN (3/13/2026, 8:00:02 PM)

3

-0.01 (-0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.99M
Revenue(TTM)37.64M
Net Income(TTM)-16.26M
AnalystsN/A
Price TargetN/A
Short Float %0.08%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-67.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS2.31
BVpS3.93
TBVpS3.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.2%
ROE -25.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.6%
FCFM N/A
ROA(3y)7.28%
ROA(5y)12.15%
ROE(3y)8.07%
ROE(5y)14.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.21%
GM growth 5YN/A
F-Score2
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 546%
Cap/Sales 42.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.19
Quick Ratio 10.19
Altman-Z 11.11
F-Score2
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)216.31%
Cap/Depr(5y)140.76%
Cap/Sales(3y)15.05%
Cap/Sales(5y)9.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-741.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.23%
Revenue growth 3Y6.54%
Revenue growth 5YN/A
Sales Q2Q%-21.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1090.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-303.31%
OCF growth 3YN/A
OCF growth 5YN/A

LICHEN INTERNATIONAL LTD / LICN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LICHEN INTERNATIONAL LTD?

ChartMill assigns a fundamental rating of 3 / 10 to LICN.


Can you provide the valuation status for LICHEN INTERNATIONAL LTD?

ChartMill assigns a valuation rating of 0 / 10 to LICHEN INTERNATIONAL LTD (LICN). This can be considered as Overvalued.


What is the profitability of LICN stock?

LICHEN INTERNATIONAL LTD (LICN) has a profitability rating of 2 / 10.


What is the financial health of LICHEN INTERNATIONAL LTD (LICN) stock?

The financial health rating of LICHEN INTERNATIONAL LTD (LICN) is 9 / 10.